The 2011 Reaxys® PhD Prize for Chemistry Research Opens for Entries
Neuchâtel, Switzerland, 2 February, 2011 - Elsevier Properties SA announces the launch of the 2011 Reaxys PhD Prize, a global competition for candidates currently studying for a PhD or having completed a PhD within the last 12 months.
The prize will be awarded for original and innovative research in organic, organometallic and inorganic chemistry to the candidates that demonstrate excellence in methodology and approach in a peer-reviewed publication. Three prize winners will each receive a check for $2000 and be invited to present their research at the Winners’ Symposium, to be held during the 14th Asian Chemical Congress, 5 – 8 September, 2011 in Bangkok, Thailand.
David Evans PhD, Scientific Affairs Director at Elsevier Properties SA said, “The Reaxys PhD Prize celebrates innovation and creativity in chemistry research from around the world, values which lie at the heart Reaxys itself.” He continued, “In 2010 we received over 300 submissions from around the world covering the breadth of modern chemistry including representatives from most of the leading chemistry universities. The quality of research was outstanding, and the finalists and winners are clearly at the cutting edge of chemistry research. A high bar has been set for 2011."
All entries will be evaluated by a review board of leading international chemists, chaired by the following members of the Reaxys Advisory Board:
- Professor A. G. M. Barrett - Imperial College London, UK
- Professor B. M. Trost - Stanford University, USA
- Professor H. N. C. Wong - Chinese University of Hong Kong, China
Submissions will be reviewed based upon originality, innovation, importance to the field, applicability, rigor of approach and publication quality.
All submissions must include a PhD Supervisor letter of recommendation, a CV and a representative peer-reviewed piece of published research. Entries should be submitted by February 28, 2011 at the Reaxys PhD Prize website: http://prize.reaxys.com
# # #
About Elsevier Properties SA
Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Trademarks including Reaxys®, PharmaPendium™ and The Lancet® are owned and protected by Elsevier Properties SA and used under license. For additional information see www.reedelsevier.com.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+31 20 485 27 36